But ultimately, adopting your method as the standard is not so much the pharma company's decision. Doctors won't routinely use it until it's endorsed by a guideline document from whatever association of infectologists publishes those guidelines, and those guidelines are only published every few years or so, at their big meetings.
Pharma representatives who pitch products to doctors do have some influence on what products those doctors use.
True, but in order to promote the product, the sales rep has to cite the supporting literature and be ready with evidence to address doctors' objections. It's another side of publish or perish.
Hey hey,
A friend and I are developing a test for antibacterial resistant infections using fluorescent dyeing that is 10 times faster than existing tests. We want to know what the process is for getting clinical laboratories to adopt our product as a standard test. This information would help us customize our prototype and pitches towards the relevant parties.